The epidemiology of co-occurring substance use and other mental disorders in Canada: Prevalence, service use, and unmet needs

Mental Disorder in Canada: An Epidemiological Perspective

Volumn , Issue , 2010, Pages 181-215

  Wild, Cameron T ^b   Urbanoski, Karen A ^a   Bassani, Diego G ^a   Castel, Saulo ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967146019     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (118)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 1990;264:2511-8.
2. Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54: 313-21.
3. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:807-16.
4. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27.
5. Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of cooccurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17-31.
6. Bland RC, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988;Suppl 338:24-32.
7. Ross HE. DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: Results from the Mental Health Supplement to the Ontario Health Survey. Drug Alcohol Depend 1995;39:111-28.
8. Scott KM, McGee MA, Oakley Browne MA, et al. Mental disorder comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006;40:875-81.
9. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry 2001;178:145-53.
10. Pirkola SP, Isometsa E, Suvisaari J, et al. DSM-IV mood, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population - results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005;40:1-10.
11. Bijl RV, Ravelli A. Psychiatric morbidity, service use, and need for care in the general population: Results of The Netherlands Mental Health Survey and Incidence Study. Am J Pub Health 2000;90:602-7.
12. Jacobi F, Wittchen H-U, Holting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34:597-611.
13. Farrell M, Howes S, Taylor C, et al. Substance misuse and psychiatric comorbidity: An overview of the OPCS National Psychiatric Morbidity Survey. Addict Behav 1998;23:909-18.
14. Bromet EJ, Gluzman SF, Paniotto VI, et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: Findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol 2005;40:681-90.
15. Vicente B, Kohn R, Rioseco P, et al. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. Am J Psychiatry 2006;163:1362-70.
16. De Graaf R, Bijl RV, Smit F, et al. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002;159:620-9.
17. Jane-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006;25: 515-36.
18. Castel S, Rush B, Urbanoski K, et al. Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service. Psychol Addict Behav 2006;20:28-35.
19. Chan Y-F, Dennis ML, Funk RR. Prevalence and comorbidity co-occurrence of major internalizing and externalizing disorders among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat 2008;34:14-24.
20. Urbanoski K, Cairney J, Adlaf E, et al. Substance abuse and quality of life among severely mentally ill consumers: A longitudinal modeling analysis. Soc Psychiatry Psychiatr Epidemiol 2007;42:810-8.
21. Berkson J. Limitations of the application of the 4-fold table analyses to hospital data. Biometrics 1946;2:47-53.
22. Bellack AS, Gearon JS. Substance abuse treatment for people with schizophrenia. Addict Behav 1998;23:749-66.
23. Havassy BE, Arns PG. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatr Serv 1998;49:935-40.
24. Havassy BE, Arns PG. Health Canada. Best Practices: Concurrent Mental Health and Substance Use Disorders. Ottawa, ON: Health Canada, 2002.
25. RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: A review of recent research. Psychiatr Serv 1999;50:1427-34.
26. Russo J, Roy-Byrne P, Reeder D, et al. Longitudinal assessment of quality of life in acute psychiatric inpatients: Reliability and validity. J Nerv Ment Dis 1997;185:166-75.
27. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 1991;179:136-8.
28. Curran GM, Sullivan G, Williams K, et al. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med 2003;41:659-67.
29. McGovern MP, Clark RE, Samnaliev M. Co-occurring psychiatric and substance use disorders: A multistate feasibility study of the quadrant model. Psychiatric Serv 2007;58:949-54.
30. Rush BR, Scott CK, Dennis ML, et al. The interaction of co-occurring psychiatric problems and recovery management checkup. Eval Rev 2008;32:7-38.
31. Rounsaville BJ, Kosten TR, Weissman MM, et al. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry 1986;43:739-45.
32. McLellan AT, Luborsky L, Woody GE, et al. Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-5.
33. Rounsaville BJ, Tierney T, Crits-Christoph K, et al. Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problems. Compr Psychiatry 1982;23:462-78.
34. Weisner C, Matzger H, Kaskutas LA. How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction 2003;98:901-911.
35. Kranzler HR, Del Boca FK, Rounsaville BJ. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: A posttreatment natural history study. J Stud Alcohol 1996;57:619-26.
36. Carroll KM, Power ME, Bryant K, et al. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993;181:71-9.
37. Carroll KM, Power ME, Bryant K, Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997;58:7-29.
38. Moos RH, Mertens JR, Brennan PL. Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. J Stud Alcohol 1994;55:561-70.
39. Booth MC, Cook CAL, Blow FC. Comorbid mental disorders in patients with AMA discharges from alcoholism treatment. Hosp Community Psychiatry 1992;43:730-1.
40. Hanson M, Kramer TH, Gross W. Outpatient treatment of adults with coexisting substance use and mental disorders. J Subst Abuse Treat 1990;7:109-16.
41. Ananth J, Vandewater S, Kamal M, et al. Missed diagnosis of substance abuse in psychiatric patients. Hosp Community Psychiatry 1989;40:297-301.
42. Barnaby B, Drummond C, McCloud A, et al. Substance misuse in psychiatric inpatients: Comparison of a screening questionnaire survey with case notes. Br Med J 2003;327:783-4.
43. Rush BR. On the screening and assessment of mental disorders among clients seeking help from specialized substance abuse treatment services: An international symposium [Editorial]. Int J Ment Health Addict 2008;6:1-6.
44. Rush BR. Substance Abuse and Mental Health Services Administration, Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. Substance Abuse and Mental Health Services Administration: Rockville, MD, 2002.
45. Rush BR. Center for Substance Abuse Treatment. Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series 42, DHHS Publication No. (SMA) 95-3061. Substance Abuse and Mental Health Services Administration: Rockville, MD, 1994.
46. Sacks S. Brief overview of screening and assessment for co-occurring disorders. Int J Ment Health Addict 2008;6:7-19.
47. Rush BR. Center for Substance Abuse Treatment, Substance Abuse Treatment for Persons with Co-occurring Disorders. Treatment Improvement Protocol (TIP) Series, 42. Substance Abuse Mental Health Services Administration: Rockville, MD, 2005.
48. O'Brien CP, Charney DS, Lewis L, et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action. Biol Psychiatry 2004;56:703-13.
49. Bellack AS, Bennett ME, Gearon JS, et al. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006;63:426-32.
50. Drake RE, Mueser KT, Brunette MF, et al. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehab J 2004;27:360-74.
51. Grella CE, Stein JA. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatric Serv 2006;57:1007-15.
52. Gravel R, Beland Y. The Canadian Community Health Survey: Mental health and well-being. Can J Psychiatry 2005;50:573-9.
53. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:93-121.
54. Kessler RC, Ustun TB. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington, DC, American Psychiatric Association, 1994.
55. Adlaf EM, Begin P, Sawka E, Canadian Addiction Survey (CAS): A National Survey of Canadian's Use of Alcohol and Other Drugs: Prevalence of Use and Related Harms: Detailed Report. Canadian Centre on Substance Abuse: Ottawa, 2005.
56. Merikangas KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893-907.
57. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
58. Offord DR, Boyle MH, Campbell D, et al. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 1996;41:559-63.
59. Veldhuizen S, Urbanoski K, Cairney J. Geographical variation in the prevalence of problematic substance use in Canada. Can J Psychiatry 2007;52:426-33.
60. Beiser M. The health of immigrants and refugees in Canada. Can J Pub Health 2005;96(suppl 2):S30-44.
61. Grant BF, Stinson FS, Hasin DS, et al. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:1226-33.
62. Alegria M, Mulvaney-Day N, Torres M, et al. Prevalence of psychiatric disorders across Latino subgroups in the United States. Am J Pub Health 2007;97:68-75.
63. Blomstedt Y, Johansson SE, Sundquist J. Mental health of immigrants from the former Soviet Bloc: A future problem for primary health care in the enlarged European Union? A cross-sectional study. BMC Pub Health 2007;7:27.
64. Claassen D, Ascoli M, Berhe T, et al. Research on mental disorders and their care in immigrant populations: A review of publications from Germany, Italy and the UK. Eur Psychiatry 2005;20:540-9.
65. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-14.
66. Ettner S, Frank R, Kessler R. The impact of psychiatric disorder on labor market outcomes. Ind Labor Relat Rev 1997;51:64-81.
67. El-Guebaly N, Currie S, Williams J, et al. Association of mood, anxiety, and substance use disorders with occupational status and disability in a community sample. Psychiatr Serv 2007;58:659-67.
68. Wang PS, Lane M, Olfson M, et al. Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:629-40.
69. Oakley Browne MA, Wells JE, McGee MA. Twelve-month and lifetime health service use in Te Rau Hinengaro: The New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006;40:855-64.
70. Harris KM, Edlund MJ. Use of mental health care and substance abusetreatment among adults with co-occurring disorders. Psychiatric Serv 2005;56:954-9.
71. Regier DA, Shapiro S, Kessler LG, et al. Epidemiology and health service resource allocation policy for alcohol, drug abuse, and mental disorders. Pub Health Rep 1984;99:483-92.
72. Regier DA, Shapiro S, Kessler LG, WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. J Am Med Assoc 2004;291:2581-90.
73. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94.
74. Bland RC, Newman SC, Orn H. Help-seeking for psychiatric disorders. Can J Psychiatry 1997;42:935-42.
75. Ross HE, Lin E, Cunningham J. Mental health service use: A comparison of treated and untreated individuals with substance use disorders in Ontario. Can J Psychiatry 1999;44:570-7.
76. Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry 1999;156:1230-6.
77. Urbanoski KA, Rush BR, Wild TC, et al. Use of mental health care services by Canadians with co-occurring substance dependence and mental disorders. Psychiatric Serv 2007;58:962-9.
78. Parikh SV, Lin E, Lesage AD. Mental health treatment in Ontario: Selected comparisons between the primary care and specialty sectors.Can J Psychiatry 1997;42:929-34.
79. Wang PS, Demler O, Olfson M, et al. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 2006;163:1187-98.
80. Meadows G, Burgess P, Bobevski I, et al. Perceived need for mental health care: Influences of diagnosis, demography and disability. Psychol Med 2002;32:299-309.
81. Bijl RV, Ravelli A. Current and residual functional disability associated with psychopathology: Findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2000;30:657-68.
82. Goering P, Lin E, Campbell D, et al. Psychiatric disability in Ontario. Can J Psychiatry 1996;41:564-71.
83. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry 2002;59:77-84.
84. Todd FC, Sellman JD, Robertson PJ. Barriers to optimal care for patients with coexisting substance use and mental health disorders. Aust N Z J Psychiatry 2002;36:792-9.
85. Young NK, Grella CE. Mental health and substance abuse treatment services for dually diagnosed clients: Results of a statewide survey of county administrators. J Behav Health Serv Res 1998;25:83-92.
86. Ware JE, Jr., Davies AR. Behavioral consequences of consumer dissatisfaction with medical care. Eval Program Plann 1983;6:291-7.
87. Lebow JL. Research assessing consumer satisfaction with mental health treatment: A review of findings. Eval Program Plann 1983;6:211-36.
88. Ducharme LJ, Knudsen HK, Roman PM. Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J 2006;42:363-75.
89. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36:1-10.
90. Wang J. Perceived barriers to mental health service use among individuals with mental disorders in the Canadian general population. Med Care 2006;44:192-5.
91. Craske MG, Edlund MJ, Sullivan G, et al. Perceived unmet need for mental health treatment and barriers to care among patients with panic disorder. Psychiatr Serv 2005;56:988-94.
92. Sareen J, Cox BJ, Afifi TO, et al. Perceived need for mental health treatment in a nationally representative Canadian sample. Can J Psychiatry 2005;50:643-51.
93. Sareen J, Jagdeo A, Cox BJ, et al. Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands. Psychiatr Serv 2007;58:357-64.
94. Wu LT, Pilowsky DJ, Schlenger WE, et al. Alcohol use disorders and the use of treatment services among college-age young adults. Psychiatr Serv 2007;58:192-200.
95. Gamma A, Angst J. Concurrent psychiatric comorbidity and multimorbidity in a community study: Gender differences and quality of life. Eur Arch Psychiatry Clin Neurosci 2001;251(suppl 2):II43-6.
96. Tracy SW, Trafton JA, Weingardt KR, et al. How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. Psychiatr Serv 2007;58:266-9.
97. Grant BF, Compton WM, Crowley TJ, et al. Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry 2007;64:379-80; author reply 381-2.
98. Cottler LB. Drug use disorders in the National Comorbidity Survey: Have we come a long way? Arch Gen Psychiatry 2007;64:380-1; author reply 381-2.
99. Fischer B, Rehm J. Illicit opioid use in the 21st century: Witnessing a paradigm shift? Addiction 2007;102:499-501.
100. Fischer B, Rehm J, Patra J, et al. Changes in illicit opioid use across Canada. Can Med Assoc J 2006;175:1385.
101. Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:361-8.
102. Brady K, Killeen T, Saladin ME, et al., Clinical and Research Reports: Comorbid Substance Abuse and Posttraumatic Stress Disorder. Rep. #3(2). The American Academy of Psychiatrists in Alcoholism and Addictions: South Carolina, 1994.
103. Perala J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19-28.
104. Wild TC, El-Guebaly N, Fischer B, et al. (2005). Comorbid depression among untreated illicit opiate users: Results from a multisite Canadian study. Can J Psychiatry 2005;50:512-8.
105. Westermeyer J, Neider J, Westermeyer M. Substance use and other psychiatric disorders among 100 American Indian patients. Cult Med Psychiatry 1992;16:519-29.
106. Duran B, Sanders M, Skipper B, et al. Prevalence and correlates of mental disorders among Native American women in primary care. Am J Pub Health 2004;94:71-7.
107. McIntyre RS, McElroy SL, Konarski JZ, et al. Problem gambling in bipolar disorder: Results from the Canadian Community Health Survey. J Affec Dis 2007;102:27-34.
108. El-Guebaly N, Patten SB, Currie S, et al. Epidemiological associations between gambling behavior, substance use and mood and anxiety disorders. J Gambl Stud 2006;22:275-87.
109. Currie SR, Patten SB, Williams JV, et al. Comorbidity of major depression with substance use disorders. Can J Psychiatry 2005;50:660-6.
110. Schaffer A, Cairney J, Cheung A, et al. Community survey of bipolar disorder in Canada: Lifetime prevalence and illness characteristics. Can J Psychiatry 2006;51:9-16.
111. Gnam W, Sarnocinska-Hart A, Mustard C, et al. The Economic Costs of Mental Disorders and Alcohol, Tobacco, and Illicit Drug Abuse in Ontario, 2000: A Cost-of-Illness Study. Centre for Addiction and Mental Health: Toronto, ON, 2006.
112. Rehm J, Baliunas D, Brochu S, et al., The Cost of Substance Abuse in Canada 2002. CCSA - CCLAT: Ottawa, ON, 2006.
113. Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care. Am J Pub Health 1996;86:973-7.
114. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;64:830-42.
115. Somers JM, Goldner EM, Waraich P, et al. Prevalence studies of substance-related disorders: A systematic review of the literature. Can J Psychiatry 2004;49:373-84.
116. Zilberman ML, Tavares H, Blume SB, et al. Substance use disorders: Sex differences and psychiatric comorbidities. Can J Psychiatry 2003;48:5-13.
117. Kirby MJL. Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada. The Standing Senate Committee on Social Affairs, Science and Technology: Ottawa, ON, 2006.
118. Somers JM. Screening for co-occurring disorders and the promotion of collaborative care. Int J Ment Health Addict 2008;6:141-4.